Lifeward announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...

CorLife, a division of Numotion, has become the exclusive distributor for Lifeward’s ReWalk Personal Exoskeleton for people with workers’ compensation claims.

Lifeward (LFWD) and CorLife jointly announced that the companies have finalized an agreement for CorLife to become the exclusive distributor ...

Last week, Lifeward said full-year revenue rose to $25.7 million from $13.9 million. It said ReWalk Personal Exoskeleton sales increased by 130% in 2024, fueled by recently established Medicare ...

(RTTNews) - Medical technology firm Lifeward Ltd. (LFWD) announced Thursday that it has received 510(k) FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7.

Lifeward Ltd. LFWD recently announced that it has received FDA 510(k) clearance for its latest innovation, the ReWalk 7 ...

Strong conclusion to 2024 with Lifeward annual revenue of $25.7 million, up 85% from 2023. ReWalk Personal Exoskeleton sales ...

FDA clearance for the newest generation of its personal exoskeleton device, the ReWalk 7. The seventh generation of the ReWalk, a wearable exoskeleton that allows individuals with spinal cord ...